Free Trial

Tilray (TLRY) Competitors

Tilray logo
$0.45 0.00 (-0.04%)
As of 05/20/2025 04:00 PM Eastern

TLRY vs. CRON, CDXC, USNA, MNMD, SNDL, ACB, CGC, MDWD, BTMD, and FTLF

Should you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), SNDL (SNDL), Aurora Cannabis (ACB), Canopy Growth (CGC), MediWound (MDWD), biote (BTMD), and FitLife Brands (FTLF). These companies are all part of the "medicinals & botanicals" industry.

Tilray vs.

Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk.

In the previous week, Tilray had 6 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Tilray and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.45 beat Tilray's score of 0.53 indicating that Cronos Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tilray
2 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray has a net margin of -30.95% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Tilray's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -2.56% -2.47%
Tilray -30.95%-4.40%-3.57%

Cronos Group has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Tilray has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500.

Tilray has a consensus target price of $1.92, indicating a potential upside of 323.20%. Given Tilray's stronger consensus rating and higher possible upside, analysts plainly believe Tilray is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tilray
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.10% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
464
61.13%
Underperform Votes
295
38.87%
TilrayOutperform Votes
448
59.10%
Underperform Votes
310
40.90%

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 9.4% of Tilray shares are held by institutional investors. 7.3% of Cronos Group shares are held by company insiders. Comparatively, 0.9% of Tilray shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cronos Group has higher earnings, but lower revenue than Tilray. Tilray is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos Group$124.59M6.47-$73.96M$0.1316.08
Tilray$210.48M2.17-$244.98M-$1.05-0.43

Summary

Cronos Group and Tilray tied by winning 9 of the 18 factors compared between the two stocks.

Get Tilray News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ Exchange
Market Cap$455.84M$1.16B$17.54B$8.48B
Dividend YieldN/AN/A3.07%4.11%
P/E Ratio-1.5110.5516.6120.05
Price / Sales2.178.444.70117.08
Price / CashN/A10.4016.3934.62
Price / Book0.111.466.224.61
Net Income-$244.98M-$54.34M$734.35M$248.19M
7 Day Performance2.61%2.72%1.20%2.97%
1 Month Performance1.18%11.88%6.01%16.58%
1 Year Performance-76.29%-38.30%-2.33%8.16%

Tilray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
1.4476 of 5 stars
$0.45
0.0%
$1.92
+323.2%
-76.7%$455.84M$210.48M-1.512,650
CRON
Cronos Group
1.0674 of 5 stars
$2.08
+1.2%
$3.50
+68.7%
-24.8%$799.72M$117.62M-15.96450Positive News
CDXC
ChromaDex
2.3512 of 5 stars
N/A$9.03
+∞
N/A$611.50M$99.60M787.29120
USNA
USANA Health Sciences
4.3666 of 5 stars
$29.50
-1.7%
$36.00
+22.0%
-38.2%$549.38M$876.24M10.421,900
MNMD
Mind Medicine (MindMed)
2.2966 of 5 stars
$6.35
-1.6%
$25.11
+295.5%
-6.5%$478.59MN/A-2.8140Positive News
Gap Up
SNDL
SNDL
3.1535 of 5 stars
$1.32
flat
$3.63
+174.6%
-44.6%$346.86M$927.61M-4.26580News Coverage
Gap Up
ACB
Aurora Cannabis
0.4589 of 5 stars
$5.25
+3.8%
N/A-27.8%$295.12M$320.81M105.021,340Gap Up
CGC
Canopy Growth
1.428 of 5 stars
$1.50
+2.4%
$2.00
+33.8%
-82.5%$274.88M$276.75M-0.393,150Trending News
Gap Up
MDWD
MediWound
1.1829 of 5 stars
$19.98
+7.1%
$29.75
+48.9%
+20.4%$215.94M$20.22M-6.8980Positive News
BTMD
biote
2.9219 of 5 stars
$3.93
-1.5%
$8.00
+103.6%
-29.4%$215.01M$197.19M15.12194Gap Up
FTLF
FitLife Brands
4.4802 of 5 stars
$15.89
+3.1%
$20.50
+29.0%
+0.9%$149.11M$64.47M18.8020Earnings Report

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners